Login / Signup

Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.

Amany M EbaidNillie EzzeldinEnas I AbdelhadyHeba A MohammedAlshimaa L Abdallah
Published in: Lupus (2022)
The serum IGBP1 levels were high in patients with LN and were positively correlated with the pathologic activity index. The serum IGBP1 level of 547.45 ng/mL is a valid biomarker for detecting active nephritis. Thus, we recommend that clinicians monitor the serum IGBP1 level of patients with SLE to detect LN.
Keyphrases
  • binding protein
  • systemic lupus erythematosus
  • palliative care
  • squamous cell carcinoma
  • neoadjuvant chemotherapy
  • disease activity
  • rheumatoid arthritis